Acromegaly Flashcards
Aetiology of acromegaly
- most common → unregulated growth hormone secretion by a pituitary adenoma
- adenoma can be microscopic or can be significantly sized that causes compression of local structures
- rarely → secondary to a cancer, such as lung or pacreatic cancer, that secretes GHRH or growth hormone.
Pathophysiology of acromegaly
- excessive GH (GH is produced by anterior pituitary gland)
Clinical presentation: overgrowth of tissues
- Prominent forehead and brow (“frontal bossing”)
- Large nose
- Large tongue (“macroglossia”)
- Large hands and feet
- Large protruding jaw (”prognathism”)
- Arthritis from imbalanced growth of joints
clinical presentation if SOL?
if pituitary tumour of sufficient size:
- starts to press on the optic chiasm → bitemporal hemaniopa (loss of vision of outer half of both eyes)
Space Occupying Lesion
- Headaches
- Visual field defect (“bitemporal hemianopia”)
Clinical presentation: GH can cause organ dysfunction:
- Hypertrophic heart
- Hypertension
- Type 2 diabetes
- Colorectal cancer
general symptoms suggesting active raised growth hormone
- Development of new skin tags
- Profuse sweating
Investiagation/Diagnosis Acromegaly
A random growth hormone level is not helpful as it will fluctuate, giving false positives and false negatives
- Insulin-like Growth Factor 1 (IGF-1) is the initial screening test (raised)
- Oral glucose tolerance test whilst measuring growth hormone (high glucose normally suppresses growth hormone)
- MRI brain for the pituitary tumour
- Refer to ophthalmology for formal visual field testing
Treatment of Acromegaly
Trans-sphenoidal (through the nose and sphenoid bone) surgical removal of thepituitary tumour is the definitive treatment of acromegaly secondary topituitary adenomas
Whereacromegalyis caused byectopichormones from a pancreatic or lung cancer, surgical removal of these cancers is the treatment.
There are medication that can be used to block growth hormone
- Pegvisomant(GH antagonist given subcutaneously and daily)
- Somatostatin analoguesto block GH release (e.g.ocreotide)
- Dopamine agoniststo block GH release (e.g.bromocriptine)